RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/24845831http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/24845831http://www.w3.org/2000/01/rdf-schema#comment"The ketone body β-hydroxybutyrate (BHB) is an endogenous factor protecting against stroke and neurodegenerative diseases, but its mode of action is unclear. Here we show in a stroke model that the hydroxy-carboxylic acid receptor 2 (HCA2, GPR109A) is required for the neuroprotective effect of BHB and a ketogenic diet, as this effect is lost in Hca2(-/-) mice. We further demonstrate that nicotinic acid, a clinically used HCA2 agonist, reduces infarct size via a HCA2-mediated mechanism, and that noninflammatory Ly-6C(Lo) monocytes and/or macrophages infiltrating the ischemic brain also express HCA2. Using cell ablation and chimeric mice, we demonstrate that HCA2 on monocytes and/or macrophages is required for the protective effect of nicotinic acid. The activation of HCA2 induces a neuroprotective phenotype of monocytes and/or macrophages that depends on PGD2 production by COX1 and the haematopoietic PGD2 synthase. Our data suggest that HCA2 activation by dietary or pharmacological means instructs Ly-6C(Lo) monocytes and/or macrophages to deliver a neuroprotective signal to the brain."xsd:string
http://purl.uniprot.org/citations/24845831http://purl.org/dc/terms/identifier"doi:10.1038/ncomms4944"xsd:string
http://purl.uniprot.org/citations/24845831http://purl.uniprot.org/core/author"Chen H."xsd:string
http://purl.uniprot.org/citations/24845831http://purl.uniprot.org/core/author"Muhammad S."xsd:string
http://purl.uniprot.org/citations/24845831http://purl.uniprot.org/core/author"Khan M.A."xsd:string
http://purl.uniprot.org/citations/24845831http://purl.uniprot.org/core/author"Rahman M."xsd:string
http://purl.uniprot.org/citations/24845831http://purl.uniprot.org/core/author"Offermanns S."xsd:string
http://purl.uniprot.org/citations/24845831http://purl.uniprot.org/core/author"Muller-Fielitz H."xsd:string
http://purl.uniprot.org/citations/24845831http://purl.uniprot.org/core/author"Okun J.G."xsd:string
http://purl.uniprot.org/citations/24845831http://purl.uniprot.org/core/author"Schwaninger M."xsd:string
http://purl.uniprot.org/citations/24845831http://purl.uniprot.org/core/author"Vollbrandt T."xsd:string
http://purl.uniprot.org/citations/24845831http://purl.uniprot.org/core/author"Nadrowitz R."xsd:string
http://purl.uniprot.org/citations/24845831http://purl.uniprot.org/core/author"Ridder D.A."xsd:string
http://purl.uniprot.org/citations/24845831http://purl.uniprot.org/core/author"Pokorna B."xsd:string
http://purl.uniprot.org/citations/24845831http://purl.uniprot.org/core/author"Stolting I."xsd:string
http://purl.uniprot.org/citations/24845831http://purl.uniprot.org/core/date"2014"xsd:gYear
http://purl.uniprot.org/citations/24845831http://purl.uniprot.org/core/name"Nat Commun"xsd:string
http://purl.uniprot.org/citations/24845831http://purl.uniprot.org/core/pages"3944"xsd:string
http://purl.uniprot.org/citations/24845831http://purl.uniprot.org/core/title"The beta-hydroxybutyrate receptor HCA2 activates a neuroprotective subset of macrophages."xsd:string
http://purl.uniprot.org/citations/24845831http://purl.uniprot.org/core/volume"5"xsd:string
http://purl.uniprot.org/citations/24845831http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/24845831
http://purl.uniprot.org/citations/24845831http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/24845831
http://purl.uniprot.org/uniprot/#_Q0VBA6-mappedCitation-24845831http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/24845831
http://purl.uniprot.org/uniprot/#_P22437-mappedCitation-24845831http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/24845831